undamentalytics Newsletter
Sign in

Pulmonx Corp revenue

Pulmonx Corp's revenue was $90.5m in fiscal 2025, up 8.0% on the year before. Since fiscal 2018 ($20.0m) it has grown at a compound 24.1% a year. Over the last twelve months it was $87.4m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue203333485469849087
Growth on the year before—+62.9%+0.4%+47.9%+10.8%+28.0%+22.0%+8.0%—
Gross profit122221364051626767
Gross margin61.4%68.8%64.8%73.6%74.3%73.9%74.0%74.2%77.1%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Geography
Region Revenue Share YoY
United States $57M 63.0% ▲ 1.0%
EMEA $27M 29.8% ▲ 20.9%
Asia Pacific $6.2M 6.9% ▲ 40.3%
Other International Geographical Areas $260,000 0.3% ▼ 53.2%

From Pulmonx Corp's 10-K filed March 10, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Pulmonx Corp $87.4m -3.4% 13.0%
Iradimed Corp $89.3m 11.0% 12.4%
Sight Sciences, Inc. $83.4m 9.3% 0.8%
Delcath Systems, Inc. $95.4m 35.8% 230.8%
Tela Bio, Inc. $79.9m 6.1% 17.6%
PRO DEX Inc $79.6m 13.3% 19.2%

Compare with peers

Head to head: IRMD vs LUNGLUNG vs SGHTDCTH vs LUNG

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Pulmonx Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Pulmonx Corp.